6505--770-25-2-801-0257 -National CMOP F0608 FERROUS SULFATE 324MG EC TAB (VA-25-00044411) 02-28-2025
ID: 36C77025Q0146Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/ebef585de4014079a6a5c49ab56cc0c8/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting bids for the procurement of Ferrous Sulfate 324mg EC Tablets as part of the National CMOP program, with a contract number of VA-25-00044411. This solicitation requires compliance with the Drug Supply Chain Security Act and mandates that contractors provide specific National Drug Codes for the pharmaceutical products offered. The successful contractor will be responsible for ensuring that all products meet FDA therapeutic equivalence codes and adhere to strict quality assurance standards, including packaging safety and recall procedures. Interested bidders should submit their quotes, including a signed SF 1449 cover page and an Excel pricing schedule, to Contract Specialist Jennifer D. Coleman at jennifer.coleman4@va.gov by the specified deadline of February 28, 2025.

    Point(s) of Contact
    Jennifer D ColemanContract Specialist
    jennifer.coleman4@va.gov
    Files
    Title
    Posted
    36C77025Q0146_1.docx
    The Department of Veterans Affairs (VA) intends to procure Ferrous Sulfate 324MG EC Tablets for its Consolidated Mail Outpatient Pharmacy (CMOP) facilities, as outlined in Solicitation Number 36C77025Q0146. The estimated issue date for responses is March 5, 2025, with quotations due by March 12, 2025. This solicitation is set aside for small businesses and requires suppliers to provide their state wholesale distributor license and compliance with the Drug Supply Chain Security Act (DSCSA). Delivery is expected within ten days after receipt of order. The document specifies packaging, quantities required at multiple VA CMOP locations, and necessary documentation for bidders, including an authorized dealer letter or OEM documentation, and a Buy American Act certificate. All submissions must be sent via email to the designated contact, Jennifer Coleman. This procurement reflects the VA's commitment to maintaining a reliable supply of essential pharmaceuticals for its facilities.
    36C77025Q0146.docx
    The document outlines a solicitation for pharmaceutical supplies for the Department of Veterans Affairs, particularly from the National Cemetery Operations Program (CMOP). It specifies essential details regarding the contract, including the solicitation number, offer due date, and the various business classifications eligible for bidding. Contractors must be compliant with the Drug Supply Chain Security Act and provide specific National Drug Codes for the products offered. The document details the required submission format for quotes, including a signed SF 1449 cover page, an Excel pricing schedule, and certifications indicating compliance with relevant laws. Furthermore, it outlines delivery requirements to multiple CMOP locations and mandates tracking information be sent upon shipment. The specifications include bar coding of products, safety standards for packaging, and recall procedures in case of product issues. The successful offeror must ensure that all products meet FDA therapeutic equivalence codes while adhering to the contract clauses and regulations indicated within the procurement framework. This solicitation emphasizes compliance, accountability, and quality assurance as paramount for contract awardees.
    Similar Opportunities
    6505--Hydroxychloroquine SO4 Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a Request for Proposal (RFP) for the procurement of Hydroxychloroquine SO4 Tablets, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will cover an estimated annual requirement of 163,395 bottles of 100-count and 25,853 bottles of 500-count Hydroxychloroquine tablets, with a contract period of one year and four optional one-year extensions. This procurement is critical for maintaining essential medications within veteran and federal healthcare programs. Interested parties should monitor SAM.gov for updates and direct inquiries to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov or (708) 786-4980, with submissions due by March 26, 2025.
    6505--Carvedilol Tablets (VA-25-00048048)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carvedilol Tablets under solicitation number 36E79725R0028, aimed at ensuring a continuous supply for various federal health care entities, including the Department of Defense and the Bureau of Prisons. The contract will be for one year, with the possibility of four additional one-year extensions, requiring offerors to supply drugs labeled with their unique National Drug Code (NDC) without altering existing labels. This procurement is critical for maintaining the availability of essential medications for veterans and affiliated populations, underscoring the VA's commitment to effective health care delivery. Interested bidders should monitor SAM.gov for updates, with the RFP expected to be issued around March 19, 2025, and responses due by April 2, 2025; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov or by phone at 708-202-9027.
    36C77025Q0138_3 Pharm CLINs Charleston CMOP
    Buyer not available
    The Department of Veterans Affairs is soliciting bids for pharmaceutical supplies under requisition number 36C77025Q0138, specifically for the Charleston Consolidated Mail Outpatient Pharmacy (CMOP). The procurement includes a variety of pharmaceutical products, with requirements for compliance with federal regulations, including packaging and barcoding standards, and mandates that all supplies must have expiration dates exceeding one year from the delivery date. This initiative is crucial for ensuring that the Department can continue to provide quality healthcare services to veterans. Interested vendors must submit their quotes, including necessary documentation, by March 10, 2025, at 3:00 PM Central Time, and can direct inquiries to Lacie A Nowak at lacie.nowak@va.gov.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Rituximab 10mg/ml and its biosimilars, aimed at establishing a reliable pharmaceutical supply source for government healthcare facilities. Bidders are required to provide unique National Drug Code (NDC) numbers for their products and include a 0.5% Cost Recovery Fee in their pricing, with the contract covering a base year and four optional subsequent years. This procurement is critical for ensuring consistent product availability and pricing based on estimated annual usage, while adhering to FDA regulations and the Drug Supply Chain Security Act (DSCSA) for safety and traceability. Interested suppliers must submit their proposals by March 11, 2025, at 2:30 PM CT, and can contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further information.
    6505--762-25-2-040-1078 -Tucson CMOP ESCITALOPRAM OXALATE -(VA-25-00049225)
    Buyer not available
    The Department of Veterans Affairs is preparing to procure Escitalopram Oxalate 20mg tablets for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). This presolicitation notice, identified by contract number 36C77025Q0169, outlines the requirement for timely delivery of the pharmaceutical product within 10 days after order receipt, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA). The procurement is set aside for small businesses under the NAICS code 325412, with a response deadline of March 13, 2025, at 3 PM Central Time. Interested vendors should submit their quotes via email, including necessary documentation, and are encouraged to monitor SAM.gov for updates.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Insulin (VA-25-00026482)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of insulin and its derivatives under the solicitation titled "6505--Insulin (VA-25-00026482)." This procurement aims to establish a reliable supply source for pharmaceutical products, specifically focusing on competitive pricing for a base year plus four option years, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and good manufacturing practices (cGMP). The contract is critical for maintaining quality healthcare for government participants, and interested offerors must submit their proposals by March 14, 2025, at 2:30 PM Central Standard Time, with all submissions including a 0.5% Cost Recovery Fee. For further inquiries, potential contractors can contact Contract Specialist Billy Fong at Billy.Fong@va.gov.
    6505--760-25-1-050-0237 -Leavenworth CMOP OM PHARMACEUTICALS -(VA-25-00028391)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a request for proposal (RFP) for the procurement of fourteen specified pharmaceuticals to be delivered to the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) facility in Kansas. This opportunity is exclusively set aside for small businesses under the product service code 6505, which pertains to drugs and biologicals, and requires interested vendors to submit a price schedule, a signed SF1449 cover page, valid state wholesale distributor licenses, and a Buy American Act certificate. The procurement is crucial for ensuring that veterans receive timely access to necessary pharmaceuticals, with the estimated RFP issue date set for March 6, 2025, and a response deadline of March 17, 2025. Interested parties should direct their submissions and inquiries to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov or by phone at 913-684-0140.
    6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
    Buyer not available
    The Department of Veterans Affairs is soliciting bids for the supply of Fluticasone Propionate nasal spray, a pharmaceutical product essential for various government healthcare facilities. Offerors are required to submit pricing for a base year and four option years, including a 0.5% Cost Recovery Fee, while ensuring compliance with federal standards and providing a unique National Drug Code (NDC) for each product. This procurement aims to secure reliable pharmaceutical sources to support healthcare services for veterans and other governmental health programs, adhering to strict FDA guidelines and good manufacturing practices. Interested contractors should contact Contract Specialist Michael J Olszewski at Michael.Olszewski@va.gov for further details on submission procedures and compliance requirements.